EZH2 and hepatocellular carcinoma: EZH2 could be recruited to the target gene/miRNA promoters via the DNA-binding protein YY1 and mediate histone H3 lysine 27 trimethylation to silence the expression of genes/miRNAs involved in skeletal muscle differentiation and hepatocellular carcinoma progression [23,24].